Seres Therapeutics Inc buy Quitte
Start price
17.08.16
/
50%
€10.03
Target price
17.02.17
€12.80
Performance (%)
-10.50%
End price
17.02.17
€8.97
Summary
This prediction ended on 17.02.17 with a price of €8.97. The prediction for Seres Therapeutics Inc disappointed with a performance of -10.50%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Seres Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by Quitte for this prediction
In the thread Seres Therapeutics Inc diskutieren
hübsches Cash-Polster
und eine üble Abstrafung lassen mich hier zuversichtlich sein
(Laufzeit überschritten)

